CLSN stock forecast
Our latest prediction for Celsion Corp.'s stock price was made on the June 19, 2019 when the stock price was at 1.82$.
In the short term (2weeks), CLSN's stock price should outperform the market by 3.84%. During that period the price should oscillate between -7.58% and +13.70%.
In the medium term (3months), CLSN's stock price should outperform the market by 6.37%. During that period the price should oscillate between -17.62% and +34.71%.Get email alerts
Create a solid portfolio with CLSN
About Celsion Corp.
Celsion Corp . is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. The firm engages in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.
At the moment the company generates 1M USD in revenues.
On its last earning announcement, the company reported a loss of -0.55$ per share.
The book value per share is 1.07$
Three months stock forecastJune 19, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|